LAM shares several features with cancer, such as estrogen receptor overexpression and dysregulation of the mammalian target of rapamycin (mTOR) pathway, leading to inappropriate proliferation, lymphangiogenesis, angiogenesis, and protease-driven matrix degradation [2]. Here, MTOR is linked to cancer.